Deb Mangone urged the Irish Government to expedite the medicines reimbursement system to reduce the current wait of up to two years for patients. At an IPHA conference, it was revealed that the HSE's assessment process far exceeds its 180-day target, taking an average of 617 days, primarily due to state delays. The Programme for Government promises quicker patient access, aligning with recommendations from a working group on reforming the approval process. Pfizer states readiness to launch 47 new medicines within a year, benefiting patients across various medical areas.
"Irish patients are waiting up to two years, sometimes even longer, for access to new medicines," she said.
"The system is no longer fit for purpose. Under the rules, the HSE is supposed to decide whether it will pay for new medicines within 180 days."
"The Programme for Government has a section headlined 'Access to new medicines and treatments.' This includes a commitment to ensure patients have access to them 'as quickly as possible.'"
"Pharmaceutical companies in Ireland expect to launch 47 new medicines in the next year, and many thousands of patients would stand to benefit across many types of cancer, plus cardiovascular disease, transplants, HIV and more."
Collection
[
|
...
]